Lv1
50 积分 2025-07-16 加入
Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35-75 years: Results from China PEACE Million Persons Project
22小时前
待确认
Familial hypercholesterolemia in China half a century: A review of published literature
1天前
已完结
AAV gene therapy for homozygous familial hypercholesterolemia: a phase 1 trial
13天前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
13天前
已完结
Glycoproteinoses: Clinical features, therapeutic landscape, and regulatory pathways in rare lysosomal disorders
24天前
已完结
Clinical Guidelines for the Diagnosis and Management of Generalized and Partial Lipodystrophies: A Position Statement Endorsed by the Hellenic Endocrine Society
1个月前
已关闭
Hypertension and clinical outcomes in patients with familial hypercholesterolemia
1个月前
已完结
Efficacy of Inclisiran in Patients Having Familial Hypercholesterolemia: Heterozygous Compared to Homozygous Trait, a Systematic Review and Meta-analysis
1个月前
已关闭
The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: A prospective cohort
1个月前
已完结
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial
1个月前
已完结
皖公网安备34019202002308
